Looking forward to the Chinese second generation covid vaccines in early next year.
On September 1st, China National Biotech announced on its official WeChat account that from September 2nd to 7th, at the 2021 China International Trade in Services Fair (hereinafter referred to as the "Service Trade Fair") in Beijing, Sinopharm Group China Biotech carries 3 diagnostic reagents in the "diagnose" field, 2 specific drugs in the "curable" field (special immunoglobulin, monoclonal antibody), and 4 new crown vaccines developed on 3 technical routes in the "preventable" field , Once again appeared at the Service Trade Fair. Among them,
the second-generation vaccine against mutant strains and two specific drugs are the world's first releases.
China Biosciences collectively refers to the exhibited products as "YYDS". The product content includes the new crown disease (Y) vaccine, specific immune (Y) globulin, single (D) clone antibody, and nucleic acid detection test (S) kit.
New crown disease (Y) vaccine:
Inactivated vaccines: At present, the two new crown inactivated vaccines of Beijing Institute of Biological Products and Wuhan Institute of Biological Products have been approved for marketing. This time,
China Biotech carries two upgraded versions of inactivated COVID-19 vaccines, and the second-generation inactivated COVID-19 vaccines that can effectively neutralize mutant strains are unveiled.
Recombinant protein new crown vaccine: This vaccine is the world's leading
broad-spectrum recombinant new crown vaccine tailored to virus mutations. From the perspective of clinical trials, this vaccine can effectively fight against mutant strains such as Delta.
New coronavirus vaccine of mRNA variant strain: With independent intellectual property rights and characteristic advantages, it is currently improving the construction of mRNA platform and the layout of large-scale production workshops.
Specific immune (Y) globulin: The new crown-specific immunoglobulin prepared from plasma containing high titer new crown antibody as a raw material is a specific new crown therapeutic drug.
Single (D) clonal antibody: a neutralizing monoclonal antibody for the new crown, which can be used as a short-term prevention for high-risk populations, and can also be used for the treatment of diseases after viral infections. It is a hot spot in global research on the prevention and control of the new crown epidemic.
Nucleic acid test (S) kit: From the new coronavirus nucleic acid test kit to the 30-minute new coronavirus nucleic acid rapid test kit, to the new coronavirus neutralizing antibody test kit, the kit has played an important role in the fight against the new coronavirus.
China Biotech stated that this year's Service Trade Fair will continue to arrange for scientific research experts to participate, face-to-face with the public, and authoritatively interpret the latest research developments in the fight against the new crown. Yang Xiaoming, chief scientist of the national "863" vaccine project and chairman of China Biotech, will attend the 2nd Global Health Beijing Forum and give a keynote speech, bringing everyone the latest achievements in China's anti-epidemic scientific research front.
In addition, China Biosciences also specially added a VR immersive interactive experience at this "Service Trade Fair", and interacted on-site to win activities such as China Biocultural and Creative Gifts.
